Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Kimia Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Kimia Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Kimia Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Jul 2025, 9:50AM Compliance-Certificate under Regulation 74(5) of SEBI(DP) Regulation 2018
  • Kimia Biosciences - ANNOUNCEMENT UNDER REGULATION 30(LODR) REGARDING THE CLARIFICAION -PRICE MOVEMENT

    2 Jul 2025, 12:52PM Announcement Under Regulation 30(LODR) regarding the Clarification on Price Movement.
  • Kimia Biosciences - Clarification sought from Kimia Biosciences Ltd

    2 Jul 2025, 12:32PM The Exchange has sought clarification from Kimia Biosciences Ltd on July 2, 2025, with reference to Movement in Price.<BR><BR>The reply is awaited.
  • Kimia Biosciences - Intimation Of Newspaper Advertisement Of Extraordinary General Meeting And E-Voting Information.\r\n

    1 Jul 2025, 3:14PM Intimation of Newspaper advertisement of Extra-Ordinary General Meeting and E-Voting.
  • Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF INTERNAL AUDITOR FOR THE FINANCIAL YEAR 2025-2026

    25 Jun 2025, 5:36PM INTIMATION FOR THE APPOINTMENT OF INTERNAL AUDITOR FOR THE FINANCIAL YEAR 2025-2026 AS PER SEBI(LODR)REGULATION 2015
  • Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF SECRETARIAL AUDITOR FOR THE FINANCIAL YEAR 2024-2025

    25 Jun 2025, 5:34PM INTIMATION FOR THE APPOINTMENT OF SECRETARIAL AUDITOR FOR THE FINANCIAL YEAR 2024-2025
  • Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF ADDITIONAL DIRECTOR ,REGULARISATION WILL BE DONE IN ENSUING EGM SCHEDUL

    25 Jun 2025, 5:31PM INTIMATION FOR THE APPOINTMENT OF ADDITIONAL DIRECTOR
  • Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF COST AUDITOR

    25 Jun 2025, 5:28PM INTIMATION FOR THE APPOINTMENT OF COST AUDITOR FOR THE FINANCIAL YEAR 2025-2026 AS PER REGULATION 30 OF SEBI(LODR) REGULATIION 2015
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    25 Jun 2025, 5:00PM Intimation of appointment of internal auditor for the financial year 2025-2026 as per the regulation 30 of SEBI(LODR)Regulation 2015
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    25 Jun 2025, 4:56PM Intimation regarding the appointment of secretarial auditor for the financial year 2024-2025 as per the SEBI (LODR),regulation 2015
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    25 Jun 2025, 4:54PM Intimation regarding the appointment of Additional director who will the regularised in the ensuing EGM which is going to be held on 22 july,2025
  • Kimia Biosciences - Disclosure under Regulation 30A of LODR

    25 Jun 2025, 4:51PM Intimation about the appointment of Cost Auditor of the company for the financial year 2025-2026.
  • Kimia Biosciences - Board Meeting Outcome for Board Meeting Outcome As Per Regulation 30SEBI(LODR)

    25 Jun 2025, 4:48PM BOARD MEETING OUCTOME AS PER REGULATION 30SEBI(LODR)
  • Kimia Biosciences - Reg. 34 (1) Annual Report.

    24 Jun 2025, 9:49PM Pursuant to Regulation 34 of SEBI(LODR)Regulations 2015,Submission of Annual Report for the financial Year 2023-2024 along with the Notice of 31st Ann
  • Kimia Biosciences - INTIMATION OF BOARD MEETING UNDER REGULATION 29(1)(D) OF SEBI (LODR) REGULATIONS,2015

    20 Jun 2025, 3:07PM Intimation Of Board meeting under regulation 29(1)(d) of SEBI (LODR)Regulation,2015
  • Kimia Biosciences - Revised Board Meeting Outcome Held On 26 May,2025 Document For The Quarter And Financial Year Ended On 31

    12 Jun 2025, 2:00PM Revised Document for the quarter and financial year ended on 31st March,2025 (Regulation 30 and 33 of the SEBI(Listing Obligation and Disclosure Requi
  • Kimia Biosciences - Non-Applicability Of Regulation 24A Of SEBI(Listing Obligation And Disclosure ),Regulations,2015

    29 May 2025, 1:56PM Non - Applicability of Regulation 24A of SEBI (Listing Obligation and Disclosure),Regulation ,2015
  • Kimia Biosciences - Financial Results Ended On 31 March 2025

    28 May 2025, 5:55PM Financial Results ended on 31 March 2025
  • Kimia Biosciences - Newspaper Publication Of Financial Results As Per Regulation 30 Of Securities Exchange Board Of India,201

    28 May 2025, 3:57PM Newspaper Publication of Financial Results for the quarter and financial year ended on 31st Mrach,2025 as per Regulation 30 of Securities Exchange Boa
  • Kimia Biosciences Q4 net profit up 10.56% at Rs 1.99 cr

    26 May 2025, 4:03PM The company reported standalone net profit of Rs 1.99 crore for the quarter ended March 31, 2025 as compared to Rs 1.80 crore in the same period last
  • Kimia Biosciences - Integrated Filing (Financial)

    26 May 2025, 3:11PM Integrated Filing (Financial) for the quarter and the financial year ended on 31st March 2025
  • Kimia Biosciences - Board Meeting Outcome for Outcome Of The Financials In The Board Meeting

    26 May 2025, 2:53PM Outcome of the Financials in the Board Meeting
  • Kimia Biosciences - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    23 May 2025, 2:34PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Kimia Biosciences - Board Meeting Intimation for Approval Of Audited Financials For The Quarter And Financial Year Ended On 3

    21 May 2025, 5:20PM Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider an
  • Kimia Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th May 2025 Pursuant To Regulation 30 Of SEB

    5 May 2025, 12:20PM Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regul
  • Kimia Biosciences - Board Meeting Intimation for Payment To Redeemable Preference Shares

    1 May 2025, 6:09PM Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2025 ,inter alia, to consider an
  • Kimia Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

    23 Apr 2025, 5:09PM Announcement under Regulation 30(LODR)-Resignation of statutory auditor.
  • Kimia Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    23 Apr 2025, 5:06PM Announcement under Regulation 30(LODR)-resignation of Chief Finance officer.
  • Kimia Biosciences - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    23 Apr 2025, 4:57PM INTIMATION UNDER REGULATION 30 OF SEBI (LISTING OBLIGATION AND DISCLOSURE RQUIREMENTS).
  • Kimia Biosciences - Board Meeting Outcome for Outcome Of Board Meeting 23.04.2025

    23 Apr 2025, 4:45PM outcome of Board Meeting ,where the board has approved and consider the appointment of statutory auditor to fill the casual vacancy and also the resig

Key fundamentals

Evaluate the intrinsic value of Kimia Biosciences Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 49.5394 63.7096 55.5039 59.9092 44.0018
Liabilities 49.5394 63.7096 55.5039 59.9092 44.0018
Equity 4.7313 4.7313 4.7313 4.7313 4.6354
Gross Profit -0.4834 -4.9759 0.6314 8.3787 4.4512
Net Profit -5.3087 -9.3522 -3.703 5.1043 1.381
Cash From Operating Activities 14.5348 -6.77 0 5.967 0.3085
NPM(%) -5.06 -7.27 -2.96 3.84 1.29
Revenue 104.8765 128.516 124.9009 132.7138 106.2863
Expenses 105.3599 133.4919 124.2695 124.3351 101.8351
ROE(%) -53.26 -93.84 -37.15 51.21 13.85

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Kimia Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 934.10 1.07 30.97 40.81 301.39 0.54
Lotus Eye Hospital and Institute Ltd 76.00 2.45 215.46 148.71 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.76 -0.91 0.00 308.78 -39.50 0.00
Astec Lifesciences Ltd 896.40 -1.42 0.00 140.24 -601.21 0.00

Company Info

Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-

Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-

Read More

Parent Organisation

Kimia Biosciences Ltd.

Founded

27/09/1993

Managing Director

Mr.Sameer Goel

NSE Symbol

FAQ

The current price of Kimia Biosciences Ltd is

The 52-week high for Kimia Biosciences Ltd is

The market capitalization of Kimia Biosciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Kimia Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Kimia Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Kimia Biosciences Ltd shares.

The CEO of Kimia Biosciences Ltd is Mr.Sameer Goel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT